These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 25061878)

  • 1. The Schlemm's canal is a VEGF-C/VEGFR-3-responsive lymphatic-like vessel.
    Aspelund A; Tammela T; Antila S; Nurmi H; Leppänen VM; Zarkada G; Stanczuk L; Francois M; Mäkinen T; Saharinen P; Immonen I; Alitalo K
    J Clin Invest; 2014 Sep; 124(9):3975-86. PubMed ID: 25061878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphatic regulator PROX1 determines Schlemm's canal integrity and identity.
    Park DY; Lee J; Park I; Choi D; Lee S; Song S; Hwang Y; Hong KY; Nakaoka Y; Makinen T; Kim P; Alitalo K; Hong YK; Koh GY
    J Clin Invest; 2014 Sep; 124(9):3960-74. PubMed ID: 25061877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel characterization and live imaging of Schlemm's canal expressing Prox-1.
    Truong TN; Li H; Hong YK; Chen L
    PLoS One; 2014; 9(5):e98245. PubMed ID: 24827370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation.
    Karpanen T; Wirzenius M; Mäkinen T; Veikkola T; Haisma HJ; Achen MG; Stacker SA; Pytowski B; Ylä-Herttuala S; Alitalo K
    Am J Pathol; 2006 Aug; 169(2):708-18. PubMed ID: 16877368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial Tyrosine Kinase Tie1 Is Required for Normal Schlemm's Canal Development-Brief Report.
    Du J; Thomson BR; Onay T; Quaggin SE
    Arterioscler Thromb Vasc Biol; 2022 Mar; 42(3):348-351. PubMed ID: 35021855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Importance of a Proteoglycan Coreceptor in Pathologic Lymphangiogenesis.
    Johns SC; Yin X; Jeltsch M; Bishop JR; Schuksz M; El Ghazal R; Wilcox-Adelman SA; Alitalo K; Fuster MM
    Circ Res; 2016 Jul; 119(2):210-21. PubMed ID: 27225479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIP1 mediates vascular endothelial cell growth factor receptor-3-dependent angiogenic and lymphangiogenic responses.
    Zhou HJ; Chen X; Huang Q; Liu R; Zhang H; Wang Y; Jin Y; Liang X; Lu L; Xu Z; Min W
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):603-15. PubMed ID: 24407031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
    Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
    J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analyses of the bone marrow kinase in the X chromosome in vascular endothelial growth factor-induced lymphangiogenesis.
    Jones D; Xu Z; Zhang H; He Y; Kluger MS; Chen H; Min W
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2553-61. PubMed ID: 20864667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
    Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
    Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble vascular endothelial growth factor receptor 3 is essential for corneal alymphaticity.
    Singh N; Tiem M; Watkins R; Cho YK; Wang Y; Olsen T; Uehara H; Mamalis C; Luo L; Oakey Z; Ambati BK
    Blood; 2013 May; 121(20):4242-9. PubMed ID: 23476047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth.
    Albuquerque RJ; Hayashi T; Cho WG; Kleinman ME; Dridi S; Takeda A; Baffi JZ; Yamada K; Kaneko H; Green MG; Chappell J; Wilting J; Weich HA; Yamagami S; Amano S; Mizuki N; Alexander JS; Peterson ML; Brekken RA; Hirashima M; Capoor S; Usui T; Ambati BK; Ambati J
    Nat Med; 2009 Sep; 15(9):1023-30. PubMed ID: 19668192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel discovery of a lymphatic bridge connecting Schlemm's canal to limbal and conjunctival lymphatic pathway.
    Yang Y; Shi M; Li G; Shen L; Chen L
    Ocul Surf; 2023 Jul; 29():272-278. PubMed ID: 37244593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study.
    Visuri MT; Honkonen KM; Hartiala P; Tervala TV; Halonen PJ; Junkkari H; Knuutinen N; Ylä-Herttuala S; Alitalo KK; Saarikko AM
    Angiogenesis; 2015 Jul; 18(3):313-26. PubMed ID: 26018927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of lymphangiogenic factors in tumor metastasis.
    He Y; Karpanen T; Alitalo K
    Biochim Biophys Acta; 2004 Mar; 1654(1):3-12. PubMed ID: 14984763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.
    Karkkainen MJ; Haiko P; Sainio K; Partanen J; Taipale J; Petrova TV; Jeltsch M; Jackson DG; Talikka M; Rauvala H; Betsholtz C; Alitalo K
    Nat Immunol; 2004 Jan; 5(1):74-80. PubMed ID: 14634646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3.
    Xu Y; Yuan L; Mak J; Pardanaud L; Caunt M; Kasman I; Larrivée B; Del Toro R; Suchting S; Medvinsky A; Silva J; Yang J; Thomas JL; Koch AW; Alitalo K; Eichmann A; Bagri A
    J Cell Biol; 2010 Jan; 188(1):115-30. PubMed ID: 20065093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model.
    Whitehurst B; Flister MJ; Bagaitkar J; Volk L; Bivens CM; Pickett B; Castro-Rivera E; Brekken RA; Gerard RD; Ran S
    Int J Cancer; 2007 Nov; 121(10):2181-91. PubMed ID: 17597103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
    Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
    Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphangiogenesis and NOS Localization in Healing Process after Tooth Extraction in Akita Mouse.
    Takahashi S; Kikuchi R; Ambe K; Nakagawa T; Takada S; Ohno T; Watanabe H
    Bull Tokyo Dent Coll; 2016; 57(3):121-31. PubMed ID: 27665690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.